Future COVID-19 Tests Could Be Based on Biomarkers and Molecular Profiles of Individuals
A new study has shown how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity. This could pave the way for better medical tests based on biomarkers and molecular profiles of individuals, to accommodate these variations in monitoring virus transmission and disease pathology, which helps guide mitigation and treatment options. More...23 Oct 2020
Advertisement
Platelia SARS-CoV-2 Total Ab Assay
In just one test, detect total anti-nucleocapsid antibodies IgM, IgA, and IgG to SARS-CoV-2 to help identify individuals exposed to SARS-CoV-2, and who have developed an adaptive immune response.
[Bio-Rad Laboratories]
Platelia SARS-CoV-2 Total Ab Assay
In just one test, detect total anti-nucleocapsid antibodies IgM, IgA, and IgG to SARS-CoV-2 to help identify individuals exposed to SARS-CoV-2, and who have developed an adaptive immune response.
[Bio-Rad Laboratories]
New COVID-19 Mass Screening Method Could Be 20 Times Cheaper Than Individual Testing
Using a new mathematical approach to screen large groups for COVID-19 could be around 20 times cheaper than individual testing, suggests a study by researchers at The University of Edinburgh (Edinburgh, UK). More...22 Oct 2020
Advertisement
Real Time RT-PCR Test for COVID-19
Detects 3 SARS-CoV-2 targets in parallel, the targets are recommended by the WHO. No other tests worldwide focuses on 3 targets.
2 controls are included: Showing the sample quality; Extraction and inhibition control.
[LINEAR CHEMICALS S.L.U]
Real Time RT-PCR Test for COVID-19
Detects 3 SARS-CoV-2 targets in parallel, the targets are recommended by the WHO. No other tests worldwide focuses on 3 targets.
2 controls are included: Showing the sample quality; Extraction and inhibition control.
[LINEAR CHEMICALS S.L.U]
Rapid COVID-19 Antigen Tests Less Effective at Detecting SARS-CoV-2 in People with Low Virus Levels, Finds Study
Researchers from the Erasmus University Medical Center (Rotterdam, the Netherlands) have cautioned that not all rapid COVID-19 antigen tests that provide results within 30 minutes may be equally effective at detecting the SARS-CoV-2 virus. More...22 Oct 2020
CerTest Biotec and BD Secure CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX System
CerTest Biotec (Zaragoza, Spain), along with Becton, Dickinson and Company (BD Franklin Lakes, NJ, USA), have announced that the VIASURE SARS-CoV-2 (N1 + N2) Real Time PCR Detection Kit adapted for the BD MAX System has been CE marked. More...22 Oct 2020
In Other News
Comprehensive Molecular Profiling Matches Pediatric Patients to Therapies
Urine-Based Liquid Biopsy Test Detects Urothelial Carcinoma
Urine-Based Liquid Biopsy Test Detects Urothelial Carcinoma
ThermoGenesis’ Breakthrough Lateral Flow Immunoassay Test Reader to Help Track Antibody Response of COVID-19 Vaccine Recipients
Saline Oral Rinse COVID-19 RT-PCR Test Could Be a Game-Changer for Coronavirus Testing
Methods for Automated Anti-Neutrophil Cytoplasmic Antibodies Compared
Methods for Automated Anti-Neutrophil Cytoplasmic Antibodies Compared
Methods for Automated Anti-Neutrophil Cytoplasmic Antibodies Compared
New Diagnostic Tests for Rotavirus and Norovirus Infections Evaluated
New Diagnostic Tests for Rotavirus and Norovirus Infections Evaluated
Breath Test Developed for Head and Neck Cancer Diagnosis
Breath Test Developed for Head and Neck Cancer Diagnosis
Analysis of Placental Cell Free DNA and RNA Predicts Gestational Complications
Glycated Albumin Levels in Tears Allow Noninvasive Glucose Testing
New Testing Process Could Make It Faster, Easier, And Less Expensive to Measure COVID-19 Antibody Levels
New Lab Testing Procedure Specifically Identifies SARS-CoV-2 Neutralizing Antibodies
New Serology Assay Accelerates COVID-19 Research through Rapid Characterization of Immune Response to SARS-CoV-2 Antigens
Engineered COVID-19 Antibody Enables Extremely Rapid Identification of SARS-CoV-2 in Nasal Mucus, Saliva, and Blood
New Rapid Lateral Flow Antigen COVID-19 Testing Platform Processes 200-300 People Each Hour and Reports Results in 15 Minutes
Novel COVID-19 Immunity Test Predicts Both Infection Risk in Healthy Individuals and Disease Severity in Patients
Mindray Hematology Solution Helps High-Volume Lab Run 2,820,000 CBC Tests Annually
Galectin-3 Predicts Cardiovascular Disease Risk in Diabetic Patients
Exome Sequencing Identifies Genetic Loci Linked to the Fetal Syndrome Nonimmune Hydrops Fetalis